Epigenetic marking and neuronal plasticity.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMID 17572174)

Published in Biol Psychiatry on July 01, 2007

Authors

Ronald S Duman1, Samuel S Newton

Author Affiliations

1: Division of Molecular Psychiatry, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508, USA. ronald.duman@yale.edu

Articles by these authors

A neurotrophic model for stress-related mood disorders. Biol Psychiatry (2006) 8.97

A negative regulator of MAP kinase causes depressive behavior. Nat Med (2010) 3.52

Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron (2003) 2.41

Antidepressant actions of the exercise-regulated gene VGF. Nat Med (2007) 1.69

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46

Sweet taste signaling functions as a hypothalamic glucose sensor. Front Integr Neurosci (2009) 1.36

Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30

Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J Neurochem (2006) 1.26

Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol (2012) 1.19

Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci (2005) 1.17

Gene profiling the response to repeated cocaine self-administration in dorsal striatum: a focus on circadian genes. Brain Res (2008) 1.09

Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry (2003) 1.09

Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol Psychiatry (2010) 1.07

A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol Psychiatry (2008) 1.06

Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol (2002) 1.04

Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav Brain Res (2008) 1.00

Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol Disord Drug Targets (2007) 0.99

Gene profiling the response to kainic acid induced seizures. Brain Res Mol Brain Res (2005) 0.99

Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord (2010) 0.94

Acetylcholinesterase inhibitors activate septohippocampal GABAergic neurons via muscarinic but not nicotinic receptors. J Pharmacol Exp Ther (2003) 0.90

Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects. Biol Psychiatry (2009) 0.88

Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression. Biol Psychiatry (2011) 0.84

Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression. Int J Neuropsychopharmacol (2011) 0.81

Downregulation of the CCAAT-enhancer binding protein beta in deltaFosB transgenic mice and by electroconvulsive seizures. Neuropsychopharmacology (2004) 0.81

Characterization of electroconvulsive seizure-induced TIMP-1 and MMP-9 in hippocampal vasculature. Int J Neuropsychopharmacol (2010) 0.78

Evaluating effects of EPO in rodent behavioral assays related to depression. Methods Mol Biol (2013) 0.77

Customizing microarrays for neuroscience drug discovery. Expert Opin Drug Discov (2007) 0.75